The lipid signal in cervical cancer: a 1H MRS pilot study
Rossella Canese1, Miriam Dolciami2, Claudia Testa3, and Lucia Manganaro2
1Core Facilities, Istituto Superiore di Sanita', Rome, Italy, 2Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I Sapienza University of Rome, Rome, Italy, 3Department of Physics and Astronomy, University of Bologna, Bologna, Italy, Rome, Italy
Cervical cancer (CC) is the fourth most common malignancy and cancer-related mortality cause in women worldwide. A significant portion of these patients are diagnosed as locally advanced cervical cancer (LACC), thus requiring combined therapies. We investigate the role of the lipid signal derived from 1H magnetic resonance (MR)-spectroscopy in assessing response to neoadjuvant chemotherapy of LACC.
This abstract and the presentation materials are available to members only;
a login is required.